Concepedia

Parallel Study Designs

Parallel Study Designs is a type of clinical trial design in which each participant is randomly assigned to receive only one treatment regimen throughout the study, thereby allowing for the comparison of different treatments between independent groups rather than within the same individuals.

2.1K

Publications

183.4K

Citations

11.3K

Authors

3.3K

Institutions

Publications per year

2017–2026

334

Variants

Parallel DesignParallel Group DesignsParallel Group Trials

Parents

Publications

2.1K

CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials

Kenneth F. Schulz, Douglas G. Altman, David Moher · BMC Medicine · 2010 · 13.5K citations · Full text

, , +16

CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials

BMJ · 2010 · 8.7K citations · Full text

, , +16

The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials

David Moher, Kenneth F. Schulz, Douglas G. Altman · The Lancet · 2001 · 5.4K citations · Full text

, , +12

The CONSORT statement: revised recommendations for improving the quality of reports of parallel group randomized trials

David Moher, Kenneth F. Schulz, Douglas G. Altman · BMC Medical Research Methodology · 2001 · 2.8K citations · Full text

, , +10

CONSORT 2010 explanation and elaboration: Updated guidelines for reporting parallel group randomised trials

David Moher, Sally Hopewell, Kenneth F. Schulz et al. · International Journal of Surgery · 2011 · 2.4K citations · Full text

, , +14

1–5 of 2.1K

Authors

11.3K

  1. DG
    Douglas G. Altman

    University of Oxford, United Kingdom

    23 publications · 38.6K citations

    22

    h-index

  2. DM
    David Moher

    Ottawa Hospital, Canada

    22 publications · 36.3K citations

    21

    h-index

  3. KF
    Kenneth F. Schulz

    Family Health International 360, United States

    19 publications · 35.9K citations

    18

    h-index

  4. JR
    Julio Rosenstock

    Dallas Diabetes Research Center, United States

    7 publications · 1.3K citations

    7

    h-index

  5. PJ
    Paul J. Hesketh

    St. Elizabeth's Medical Center, United States

    6 publications · 473 citations

    6

    h-index

1–5 of 11.3K

Institutions

3.3K

  1. Eli Lilly (United States)

    Indianapolis, United States

    28 h-index

    116 publications

    9.3K citations

  2. Novartis (Switzerland)

    Basel, Switzerland

    25 h-index

    120 publications

    6.7K citations

  3. Pfizer (United States)

    New York, United States

    22 h-index

    118 publications

    6K citations

  4. Novartis (United States)

    New York, United States

    21 h-index

    83 publications

    7.4K citations

  5. University of Oxford

    Oxford, United Kingdom

    20 h-index

    26 publications

    47.8K citations

  6. Massachusetts General Hospital

    Boston, United States

    19 h-index

    29 publications

    2K citations

  7. Family Health International 360

    Durham, United States

    18 h-index

    21 publications

    60.4K citations

  8. Baylor College of Medicine

    Houston, United States

    17 h-index

    56 publications

    8.9K citations

1–8 of 3.3K

Venues

  1. PubMed

    Repository · 219 publications · 7.2K citations

    45

    h-index

  2. Clinical Therapeutics

    48 publications · 3.2K citations

    28

    h-index

  3. Diabetes Care

    25 publications · 4.9K citations

    25

    h-index

  4. Neurology

    24 publications · 4.3K citations

    23

    h-index

  5. The Journal of Clinical Pharmacology

    35 publications · 1.7K citations

    23

    h-index

1–5